News & Articles
inSeption Group Partners with Pennsylvania Biotechnology Center
FOR IMMEDIATE RELEASE inSeption Group Partners with Pennsylvania Biotechnology Center to Support […]
Read More....Recovering A Clinical Trial That Has Been Derailed
When your asset is on the line, your partner of choice matters […]
Read More....Dawn Niccum Named CPR Chair-Elect, 2024
inSeption Group is thrilled to announce that Dawn Niccum has been designated […]
Read More....Entrepreneur of the Year
inSeption Group Co-Founders and Managing Partners Joe Arcangelo and Brian Sulpizio Named […]
Read More....Philadelphia Business Journal’s Fast 50 Growing Companies 2024
[Lansdale, PA] – [August 13th, 2024] – inSeption Group, a leading clinical outsourcing […]
Read More....How To Build Effective Clinical Trial Oversight And Leadership
Sponsor-led oversight is critical in clinical trials, even when strategic input and […]
Read More....High-Velocity Development: Gene Therapy Vs. Small Molecule
Gene therapy development operates at a high velocity compared to small molecule […]
Read More....Rare Disease Clinical Endpoints: Ingenuity Meets Practicality
Discover why the science that brought you to this point can only […]
Read More....CRAs Must Evolve Alongside Oncology Therapeutics
Clinical Research Associates (CRAs) must adapt to the evolving demands of oncology […]
Read More....FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
Integrating Quality by Design (QbD) and Risk-Based Monitoring (RBM) approaches in clinical […]
Read More....